Literature DB >> 9058378

Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.

A C Maiyar1, P T Phu, A J Huang, G L Firestone.   

Abstract

sgk is a novel member of the serine/threonine protein kinase family that is transcriptionally regulated by serum and glucocorticoids in Rat2 fibroblasts and in mammary epithelial cells. 5'-Deletion analysis of the sgk promoter, using a series of sgk-CAT. (chloramphenicol acetyltransferase) chimeric reporter gene plasmids, defined a glucocorticoid-responsive region that contains a glucocorticoid response element (sgkGRE) between -1000 and -975 bp. The sgkGRE is specifically bound by glucocorticoid receptors and is sufficient to confer glucocorticoid responsiveness to a heterologous promoter in several cell lines. Strikingly, cotransfection of either the murine or human wild type p53, but not a mutant p53, repressed the dexamethasone-stimulated transactivation of reporter plasmids containing either the sgkGRE or a consensus GRE. Gel shift analysis revealed that in vitro synthesized p53 prevented binding of the glucocorticoid receptor both to the sgkGRE as well as to a consensus GRE. The p53-mediated repression of dexamethasone-induced sgkGRE activity required both the DNA binding and transactivation functions of the p53 protein. Activation of endogenous p53, by exposure to UV light, repressed the glucocorticoid receptor transactivation of a consensus GRE-CAT reporter plasmid in transfected cells. Conversely, activated glucocorticoid receptors suppressed the transactivation function of p53, while transrepression by p53 was largely unaffected. The presented data demonstrate that sgk is a primary glucocorticoid-responsive protein kinase gene that implicates a new pathway of cross-talk between steroid receptor signaling and cellular phosphorylation cascades. In addition, our study provides the first evidence of mutual interference of transactivation functions of p53 and the glucocorticoid receptor, possibly through their direct interaction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9058378     DOI: 10.1210/mend.11.3.9893

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  29 in total

1.  Glucocorticoids exacerbate hypoxia-induced expression of the pro-apoptotic gene Bnip3 in the developing cortex.

Authors:  U S Sandau; R J Handa
Journal:  Neuroscience       Date:  2006-11-15       Impact factor: 3.590

2.  Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic.

Authors:  Andrea B Sherk; Daniel E Frigo; Christine G Schnackenberg; Jeffrey D Bray; Nicholas J Laping; Walter Trizna; Marlys Hammond; Jaclyn R Patterson; Scott K Thompson; Dmitri Kazmin; John D Norris; Donald P McDonnell
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

Review 3.  Corticosteroids in the brain. Cellular and molecular actions.

Authors:  M Joëls; E Vreugdenhil
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

4.  Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene.

Authors:  Yutaka Maeda; Wendy W Hwang-Verslues; Gang Wei; Takuya Fukazawa; Mary L Durbin; Laurie B Owen; Xuan Liu; Frances M Sladek
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

5.  Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway.

Authors:  J Park; M L Leong; P Buse; A C Maiyar; G L Firestone; B A Hemmings
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

6.  Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2.

Authors:  T Kobayashi; P Cohen
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

7.  Glucocorticoids can activate the alpha-ENaC gene promoter independently of SGK1.

Authors:  Niall McTavish; Jennet Getty; Ann Burchell; Stuart M Wilson
Journal:  Biochem J       Date:  2009-09-25       Impact factor: 3.857

8.  Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation.

Authors:  Rosario Amato; Lucia D'Antona; Giovanni Porciatti; Valter Agosti; Miranda Menniti; Cinzia Rinaldo; Nicola Costa; Emanuele Bellacchio; Stefano Mattarocci; Giorgio Fuiano; Silvia Soddu; Marco G Paggi; Florian Lang; Nicola Perrotti
Journal:  J Mol Med (Berl)       Date:  2009-09-11       Impact factor: 4.599

9.  The presence of p53 influences the expression of multiple human cytomegalovirus genes at early times postinfection.

Authors:  Holger Hannemann; Kyle Rosenke; John M O'Dowd; Elizabeth A Fortunato
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

10.  Molecular characterization of SMILE as a novel corepressor of nuclear receptors.

Authors:  Yuan-Bin Xie; Balachandar Nedumaran; Hueng-Sik Choi
Journal:  Nucleic Acids Res       Date:  2009-05-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.